Feasibility Study of Neoadjuvant Chemotherapy Modified FOLFOX6 for Resectable Liver Metastases of Colorectal Cancers
The purpose of this study is to evaluate the safety of liver resection for metastatic, resectable lesions from colorectal cancers after systemic chemotherapy.
Colorectal Cancer|Liver Metastasis
PROCEDURE: Surgery
Curative resection rates of liver metastases, 2 years after the operations
Completion rates of neoadjuvant chemotherapy, 2 years after the operation
The purpose of this study is to evaluate the safety of liver resection for metastatic, resectable lesions from colorectal cancers after systemic chemotherapy.